Abstract
Inhibition of Complement C1s By Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Efficacy and Safety Results from the Randomized, Placebo-Controlled Phase 3 CADENZA Study
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have